在慢性病患者的Inclisiran:一个现实世界的经验
Cardiorenal medicine
|February 4, 2026
概括
在慢性病患者中,Inclisiran有效降低胆固醇,患者不能耐受他类药物. 这种siRNA疗法提供了一个安全的替代方案,可以达到目标的LDL胆固醇水平,没有显著的副作用.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心血管疾病是慢性病 (CKD) 患者的主要关注点.
- 高胆固醇血症,特别是高的LDL胆固醇,是CKD的重要心血管风险因素.
- 作为一线治疗方法的他类药物,常常是慢性结核病患者所能承受的不好,原因是诸如拉布地溶解之类的副作用.
研究的目的:
- 评估Inclisiran作为CKD患者高胆固醇血症治疗的替代方案的疗效和安全性.
- 评估Inclisiran对LDL胆固醇和估计的淋巴细胞过率 (eGFR) 的影响.
主要方法:
- 一项观察性研究包括32名CKD患者 (平均年龄为60.2岁),患有高胆固醇血清和冠状动脉疾病.
- 患者在基线,3个月和6个月接受Inclisiran 284 mg.
- 平均基线EGFR为36.93毫升/分钟/米2;4名患者患有2型糖尿病.
主要成果:
- 在12个月后,Inclisiran治疗导致总和LDL胆固醇减少近50%.
- 在研究期间,没有观察到eGFR值的显著变化.
- 一名患者心肌梗塞;没有报告与药物相关的副作用.
结论:
- 在不耐受他的CKD患者中,Inclisiran为高胆固醇血症提供了可行的治疗选择.
- 该治疗有效地实现了指南推的LDL胆固醇目标.
- 在这个患者队列中,Inclisiran表现出良好的安全性.
更多相关视频
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
1.6K
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
24.4K
相关概念视频
01:25Chronic Kidney Disease I: Introduction
739
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
739
01:24Chronic Kidney Disease II: Clinical Manifestations
664
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
664
01:28Chronic Kidney Disease III: Interprofessional Care
478
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
478
01:18Chronic Kidney Disease IV: Nursing Management
397
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
397
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.6K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.6K